Share the Tech If mRNA vaccine technology from Moderna, BioNTech and Pfizer were shared, manufacturers in low- and middle-income countries could produce vaccines for global pandemic preparedness, as well as diseases of concern such as HIV, TB and malaria.
Shailly Gupta @MSF_access cautions against taking a ‘business-as-usual’ approach by continuing to rely on the current market-based research and development paradigm that has largely failed to deliver new antibiotics. msfaccess.org/msf-response-g… twitter.com/IFPMA/status/1… 02:00 - 09 Jul 2020